These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20007380)

  • 1. Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States.
    Iqbal N; DeBess EE; Wohrle R; Sun B; Nett RJ; Ahlquist AM; Chiller T; Lockhart SR;
    J Clin Microbiol; 2010 Feb; 48(2):539-44. PubMed ID: 20007380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States.
    Byrnes EJ; Bildfell RJ; Frank SA; Mitchell TG; Marr KA; Heitman J
    J Infect Dis; 2009 Apr; 199(7):1081-6. PubMed ID: 19220140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
    Hagen F; Hare Jensen R; Meis JF; Arendrup MC
    Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal drug susceptibility and phylogenetic diversity among Cryptococcus isolates from dogs and cats in North America.
    Singer LM; Meyer W; Firacative C; Thompson GR; Samitz E; Sykes JE
    J Clin Microbiol; 2014 Jun; 52(6):2061-70. PubMed ID: 24696030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azole resistance in Cryptococcus gattii from the Pacific Northwest: Investigation of the role of ERG11.
    Gast CE; Basso LR; Bruzual I; Wong B
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5478-85. PubMed ID: 23979758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility to antifungal agents and genotypes of Brazilian clinical and environmental Cryptococcus gattii strains.
    Silva DC; Martins MA; Szeszs MW; Bonfietti LX; Matos D; Melhem MS
    Diagn Microbiol Infect Dis; 2012 Apr; 72(4):332-9. PubMed ID: 22341512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo development of fluconazole resistance in serial Cryptococcus gattii isolates from a cat.
    Sykes JE; Hodge G; Singapuri A; Yang ML; Gelli A; Thompson GR
    Med Mycol; 2017 Jun; 55(4):396-401. PubMed ID: 28339594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular types of Cryptococcus neoformans and Cryptococcus gattii in Western Australia and correlation with antifungal susceptibility.
    Lee GA; Arthur I; Merritt A; Leung M
    Med Mycol; 2019 Nov; 57(8):1004-1010. PubMed ID: 30649538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterisation and antifungal susceptibility of clinical Cryptococcus deuterogattii (AFLP6/VGII) isolates from Southern Brazil.
    Herkert PF; Hagen F; de Oliveira Salvador GL; Gomes RR; Ferreira MS; Vicente VA; Muro MD; Pinheiro RL; Meis JF; Queiroz-Telles F
    Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1803-1810. PubMed ID: 27477855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptococcus gattii in the United States: genotypic diversity of human and veterinary isolates.
    Lockhart SR; Iqbal N; Harris JR; Grossman NT; DeBess E; Wohrle R; Marsden-Haug N; Vugia DJ
    PLoS One; 2013; 8(9):e74737. PubMed ID: 24019979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiological characteristics of clinical isolates of Cryptococcus spp. in Bahia, Brazil: molecular types and antifungal susceptibilities.
    Matos CS; de Souza Andrade A; Oliveira NS; Barros TF
    Eur J Clin Microbiol Infect Dis; 2012 Jul; 31(7):1647-52. PubMed ID: 22278291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcus gattii genotype VGIIa infection imported from Vancouver Island to Japan.
    Kitaura T; Takahashi M; Umeyama T; Takeshita N; Katanami Y; Takaya S; Yamamoto K; Kutsuna S; Hayakawa K; Kato Y; Yamauchi T; Narita Y; Miyazaki Y; Ohmagari N
    J Infect Chemother; 2018 Jul; 24(7):573-575. PubMed ID: 29352650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time PCR assays for genotyping of Cryptococcus gattii in North America.
    Kelley EJ; Driebe EM; Etienne K; Brandt ME; Schupp JM; Gillece JD; Trujillo JS; Lockhart SR; Deak E; Keim PS; Engelthaler DM
    BMC Microbiol; 2014 May; 14():125. PubMed ID: 24886039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated dormant Cryptococcus gattii infection in a Dutch tourist who visited Vancouver Island (Canada): a molecular epidemiological approach.
    Hagen F; van Assen S; Luijckx GJ; Boekhout T; Kampinga GA
    Med Mycol; 2010 May; 48(3):528-31. PubMed ID: 19824880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
    Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
    Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole genome sequence analysis of Cryptococcus gattii from the Pacific Northwest reveals unexpected diversity.
    Gillece JD; Schupp JM; Balajee SA; Harris J; Pearson T; Yan Y; Keim P; DeBess E; Marsden-Haug N; Wohrle R; Engelthaler DM; Lockhart SR
    PLoS One; 2011; 6(12):e28550. PubMed ID: 22163313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of the yeast pathogen cryptococcus to fluconazole and other azoles varies with molecular genotype.
    Chong HS; Dagg R; Malik R; Chen S; Carter D
    J Clin Microbiol; 2010 Nov; 48(11):4115-20. PubMed ID: 20844209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
    Souza LK; Souza Junior AH; Costa CR; Faganello J; Vainstein MH; Chagas AL; Souza AC; Silva MR
    Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans/C. gattii species complex.
    Trilles L; Meyer W; Wanke B; Guarro J; Lazéra M
    Med Mycol; 2012 Apr; 50(3):328-32. PubMed ID: 21859388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A decade of experience: Cryptococcus gattii in British Columbia.
    Bartlett KH; Cheng PY; Duncan C; Galanis E; Hoang L; Kidd S; Lee MK; Lester S; MacDougall L; Mak S; Morshed M; Taylor M; Kronstad J
    Mycopathologia; 2012 Jun; 173(5-6):311-9. PubMed ID: 21960040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.